Cargando…

Protective Effect of Keluoxin against Diabetic Nephropathy in Type 2 Diabetic Mellitus Models

Diabetic nephropathy (DN) is a chronic kidney disease that develops in patients with diabetes mellitus (DM). Renal dysfunction and persistent proteinuria are the main clinical features of DN. Podocyte injury is an important cause of persistent proteinuria and diabetic kidney disease (DKD) progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaomei, Han, Xuke, Wen, Qing, Qiu, Xianliang, Deng, Huan, Chen, Qiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548109/ https://www.ncbi.nlm.nih.gov/pubmed/34712350 http://dx.doi.org/10.1155/2021/8455709

Ejemplares similares

Combining network pharmacology and in vitro and in vivo experiments to study the mechanism of Keluoxin in the treatment of radiation nephropathy
por: Deng, Lin, et al.
Publicado: (2023)

Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy
por: Kong, Ling, et al.
Publicado: (2022)

Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Wang, Xian, et al.
Publicado: (2020)

Efficacy and safety of Keluoxin capsule in combination with Western medicine for diabetic kidney disease: A systematic review and meta-analysis
por: Zhang, Wenhua, et al.
Publicado: (2023)

Effect of Electroacupuncture on Bladder Dysfunction via Regulation of MLC and MLCK Phosphorylation in a Rat Model of Type 2 Diabetes Mellitus
por: Han, Xuke, et al.
Publicado: (2021)

Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy
por: Fan, Gang, et al.
Publicado: (2023)

Effects of electroacupuncture on bladder dysfunction and the expression of PACAP38 in a diabetic rat model
por: Han, Xuke, et al.
Publicado: (2023)

A Nomogram Model that Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Retrospective Study
por: Xi, Chunfeng, et al.
Publicado: (2021)

Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial
por: Wu, Rui, et al.
Publicado: (2020)

CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice
por: Peng, Zining, et al.
Publicado: (2023)

Identifying Parameters to Distinguish Non-Diabetic Renal Diseases from Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
por: Liang, Shuang, et al.
Publicado: (2013)

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus
por: Wheelock, Kevin M., et al.
Publicado: (2017)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

Podocyte ACE2 protects against diabetic nephropathy
por: Harris, Raymond C.
Publicado: (2012)

Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach
por: Ge, Nan, et al.
Publicado: (2021)

Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis
por: Wang, Shengju, et al.
Publicado: (2020)

Experimental model of nephropathy associated with diabetes mellitus in mice
por: Silva, Pâmela Henrique, et al.
Publicado: (2023)

Urinary nephrin linked nephropathy in type-2 diabetes mellitus
por: Rangaswamaiah, Hareesh, et al.
Publicado: (2022)

Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
por: Li, Xu, et al.
Publicado: (2017)

Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
por: Bell, Christopher G, et al.
Publicado: (2010)

Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy
por: Pan, Lianlian, et al.
Publicado: (2018)

Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus
por: Hu, Fan, et al.
Publicado: (2020)

Concurrent Presentation of Diabetic Nephropathy and Type 1 Diabetes Mellitus in a Pediatric Patient
por: Manazir, Sana, et al.
Publicado: (2021)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
por: Baek, Jong Ha, et al.
Publicado: (2021)

Early functional and metabolic disorders in children with type 1 diabetes mellitus and diabetic nephropathy
por: Burlaka, Ievgeniia, et al.
Publicado: (2021)

Exploring the Correlates of Hematological Parameters With Early Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Chollangi, Susmitha, et al.
Publicado: (2023)

The diagnostic model for early detection of gestational diabetes mellitus and gestational diabetic nephropathy
por: Chong, Huimin, et al.
Publicado: (2022)

Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
por: Ding, Dan, et al.
Publicado: (2015)

Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus
por: Wan, Shu-jun, et al.
Publicado: (2022)

Zebrafish: A Model to Study and Understand the Diabetic Nephropathy and Other Microvascular Complications of Type 2 Diabetes Mellitus
por: Sharchil, Charles, et al.
Publicado: (2022)

Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
por: Song, Ki‐Ho, et al.
Publicado: (2018)

Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy
por: Wang, Xin, et al.
Publicado: (2017)

Mannose-binding lectin activation is associated with the progression of diabetic nephropathy in type 2 diabetes mellitus patients
por: Cai, Kedan, et al.
Publicado: (2020)

Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1
por: Lei, Chuntao, et al.
Publicado: (2022)

The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus
por: Zhang, Junlin, et al.
Publicado: (2018)

Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus
por: De Muro, Pierina, et al.
Publicado: (2016)

Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus
por: Domingueti, Caroline Pereira, et al.
Publicado: (2016)

Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
por: Palazhy, Sabitha, et al.
Publicado: (2017)

Association Between Globulin and Diabetic Nephropathy in Type2 Diabetes Mellitus Patients: A Cross-Sectional Study
por: Wang, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eoo332pr9n8ct2cs29q9j4dob6